Australian Genomic Cancer Medicine Centre Limited

Outsmarting Cancer, Together - Omico

A nationwide network of research and treatment centres that facilitates, supports, and promotes clinical trials in genomic cancer medicine. Facilitating, supporting, and promoting clinical trials in genomic cancer medicine. Australian Genomic Cancer Medicine Centre is a national organisation bringing together major cancer treatment centres, leading research institutions and industry to deliver the next generation of treatment options and better outcomes to Australian cancer patients.
67627640733
IČO
NSW 2052
Adresa
omico.com.au
Web
OmicoAustralia
Twitter (513)
omicoaustralia
Facebook (292)

Novinky

Poslední komentáře

So inspiring to see how Omico is bringing together so many talented minds to tackle cancer! Every step towards precision oncology is a step towards hope for patients and families. 💪💖
detail
Amazing work, Omico! Your commitment to improving cancer outcomes through innovative clinical trials is truly making a difference in the lives of so many Australians. Keep pushing forward! 🌟🧬
detail

Poslední diskuze

1. How can we enhance patient recruitment strategies for clinical trials in genomic cancer medicine to ensure diverse representation across Australia?
Odpovědí: 3, Naposledy před 1 den detail
2. What role do you think government policy should play in supporting the funding and infrastructure for genomic cancer research and clinical trials?
Odpovědí: 3, Naposledy před 1 den detail

V okolí

Kontaktovat
Australian Genomic Cancer Medicine Centre Limited logo
Australian Genomic Cancer Medicine Centre Limited
+ Sledovat
4.5
Reviews
NSW 2052
Místo
O společnosti

- E70, E61 -

PROGRAMS CLINICAL TRIALS Together cancer meets its match Omico is changing the way we fight cancer by accelerating access to precision oncology. We are a national independent notforprofit organisation uniting Australias worldclass cancer institutes researchers clinicians industry partners and government like never before. By leveraging a nationwide network of expertise and resources we aim to improve outcomes for all Australian cancer patients. With fasttracked molecular and genomic screening biomarkerled trial set up and patient enrolment from the entire nation were accelerating access to next generation treatments and preventive strategies.

Programy veřejného zdraví Související s dodávkou krve
23 Vacancy More Detail